https://www.selleckchem.com/pr....oducts/crt-0105446.h
The model further stratified clinical subgroups usually considered prognostically homogeneous such as patients with bone-only or liver metastases. Bone-only disease classified as Simulatedaggressive had a significantly worse overall survival (OS; P less then .0001), while patients with liver metastases classified as Simulatedindolent had a significantly better prognosis (P less then .0001). Consistent results were observed for patients who had undergone CTCs enumeration in the pooled population. The differential prognostic impact of